This Blue Paper was prepared as a result of a roundtable discussion organised by the Takshashila Institution on 15 December 2017, based on the Discussion Document: A Framework for Governing Gene Editing.
The discussion document develops a framework to analyse gene editing technologies. The paper explores three broad categories, corresponding to the stage of development of the technology: Fundamental R&D, Commercial R&D and Commercialisation. Each of these groups requires a different governance principle. This idea is used to develop a three-level framework to govern gene editing technologies.
The Blue Paper highlights the recommendations of the all participants at the roundtable discussion, which was chaired by Dr. Vijay Chandru.
Tagged: Ajay Patri, Anirudh Kanisetti, CRISPR Cas9, discussion document, Framework, Gene Editing, Gene Editing Technologies, Governing Gene Editing, Madhav Chandavarkar, public policy, roundtable discussion, Shambhavi Naik, Takshashila Blue Paper, The Takshashila Institution